Cargando…

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort

INTRODUCTION: Clinical trials have demonstrated that treatment-to-target (T2T) is effective in achieving remission in early rheumatoid arthritis (RA). However, the concept of T2T has not been fully implemented yet and the question is whether a T2T strategy is feasible in daily clinical practice. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeer, Marloes, Kuper, Hillechiena H, Bernelot Moens, Hein J, Hoekstra, Monique, Posthumus, Marcel D, van Riel, Piet LCM, van de Laar, Mart AFJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674614/
https://www.ncbi.nlm.nih.gov/pubmed/23176083
http://dx.doi.org/10.1186/ar4099
_version_ 1782272392010137600
author Vermeer, Marloes
Kuper, Hillechiena H
Bernelot Moens, Hein J
Hoekstra, Monique
Posthumus, Marcel D
van Riel, Piet LCM
van de Laar, Mart AFJ
author_facet Vermeer, Marloes
Kuper, Hillechiena H
Bernelot Moens, Hein J
Hoekstra, Monique
Posthumus, Marcel D
van Riel, Piet LCM
van de Laar, Mart AFJ
author_sort Vermeer, Marloes
collection PubMed
description INTRODUCTION: Clinical trials have demonstrated that treatment-to-target (T2T) is effective in achieving remission in early rheumatoid arthritis (RA). However, the concept of T2T has not been fully implemented yet and the question is whether a T2T strategy is feasible in daily clinical practice. The objective of the study was to evaluate the adherence to a T2T strategy aiming at remission (Disease Activity Score in 28 joints (DAS28) < 2.6) in early RA in daily practice. The recommendations regarding T2T included regular assessment of the DAS28 and advice regarding DAS28-driven treatment adjustments. METHODS: A medical chart review was performed among a random sample of 100 RA patients of the DREAM remission induction cohort. At all scheduled visits, it was determined whether the clinical decisions were compliant to the T2T recommendations. RESULTS: The 100 patients contributed to a total of 1,115 visits. The DAS28 was available in 97.9% (1,092/1,115) of the visits, of which the DAS28 was assessed at a frequency of at least every three months in 88.3% (964/1,092). Adherence to the treatment advice was observed in 69.3% (757/1,092) of the visits. In case of non-adherence when remission was present (19.5%, 108/553), most frequently medication was tapered off or discontinued when it should have been continued (7.2%, 40/553) or treatment was continued when it should have been tapered off or discontinued (6.2%, 34/553). In case of non-adherence when remission was absent (42.1%, 227/539), most frequently medication was not intensified when an intensification step should have been taken (34.9%, 188/539). The main reason for non-adherence was discordance between disease activity status according to the rheumatologist and DAS28. CONCLUSIONS: The recommendations regarding T2T were successfully implemented and high adherence was observed. This demonstrates that a T2T strategy is feasible in RA in daily clinical practice.
format Online
Article
Text
id pubmed-3674614
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36746142013-06-10 Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort Vermeer, Marloes Kuper, Hillechiena H Bernelot Moens, Hein J Hoekstra, Monique Posthumus, Marcel D van Riel, Piet LCM van de Laar, Mart AFJ Arthritis Res Ther Research Article INTRODUCTION: Clinical trials have demonstrated that treatment-to-target (T2T) is effective in achieving remission in early rheumatoid arthritis (RA). However, the concept of T2T has not been fully implemented yet and the question is whether a T2T strategy is feasible in daily clinical practice. The objective of the study was to evaluate the adherence to a T2T strategy aiming at remission (Disease Activity Score in 28 joints (DAS28) < 2.6) in early RA in daily practice. The recommendations regarding T2T included regular assessment of the DAS28 and advice regarding DAS28-driven treatment adjustments. METHODS: A medical chart review was performed among a random sample of 100 RA patients of the DREAM remission induction cohort. At all scheduled visits, it was determined whether the clinical decisions were compliant to the T2T recommendations. RESULTS: The 100 patients contributed to a total of 1,115 visits. The DAS28 was available in 97.9% (1,092/1,115) of the visits, of which the DAS28 was assessed at a frequency of at least every three months in 88.3% (964/1,092). Adherence to the treatment advice was observed in 69.3% (757/1,092) of the visits. In case of non-adherence when remission was present (19.5%, 108/553), most frequently medication was tapered off or discontinued when it should have been continued (7.2%, 40/553) or treatment was continued when it should have been tapered off or discontinued (6.2%, 34/553). In case of non-adherence when remission was absent (42.1%, 227/539), most frequently medication was not intensified when an intensification step should have been taken (34.9%, 188/539). The main reason for non-adherence was discordance between disease activity status according to the rheumatologist and DAS28. CONCLUSIONS: The recommendations regarding T2T were successfully implemented and high adherence was observed. This demonstrates that a T2T strategy is feasible in RA in daily clinical practice. BioMed Central 2012 2012-11-23 /pmc/articles/PMC3674614/ /pubmed/23176083 http://dx.doi.org/10.1186/ar4099 Text en Copyright ©2012 Vermeer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Vermeer, Marloes
Kuper, Hillechiena H
Bernelot Moens, Hein J
Hoekstra, Monique
Posthumus, Marcel D
van Riel, Piet LCM
van de Laar, Mart AFJ
Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
title Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
title_full Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
title_fullStr Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
title_full_unstemmed Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
title_short Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
title_sort adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the dream remission induction cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674614/
https://www.ncbi.nlm.nih.gov/pubmed/23176083
http://dx.doi.org/10.1186/ar4099
work_keys_str_mv AT vermeermarloes adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort
AT kuperhillechienah adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort
AT bernelotmoensheinj adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort
AT hoekstramonique adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort
AT posthumusmarceld adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort
AT vanrielpietlcm adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort
AT vandelaarmartafj adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort